Polymers in Medicine

Polim. Med.
Scopus CiteScore: 3.5 (CiteScore Tracker 3.6)
Index Copernicus (ICV 2023) – 121.14
MEiN – 70
ISSN 0370-0747 (print)
ISSN 2451-2699 (online) 
Periodicity – biannual

Download PDF

Polymers in Medicine

2015, vol. 45, nr 2, July-December, p. 57–65

doi: 10.17219/pim/60583

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Development of Metronidazole-Loaded Colon-Targeted Microparticulate Drug Delivery System

Manoj Kumar1,A,B,C, Rajendra Awasthi1,A,B,C,D,E,F

1 Department of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, Tehsil-Dehra, Distt-Kangra, Himachal Pradesh, India

Abstract

Background. Crohn’s disease and ulcerative colitis are the main autoimmune inflammatory bowel diseases. Metronidazole is the most commonly used drug for the treatment of Crohn’s disease. However, the pharmacokinetic profile of this drug indicates that the largest amount of the drug is absorbed from the upper part of the intestines and very little concentration of the drugs reaches the colon.
Objectives. The aim of this investigation was to formulate metronidazole loaded microspheres for the efficient therapy of inflammatory bowel diseases.
Material and Methods. Microspheres were prepared using the emulsification-solvent evaporation method. The effect of Eudragit S100 concentration and the ratio of liquid paraffin (light: heavy) on percentage yield, particle size, morphology, drug encapsulation and in vitro drug release was examined. Drug-polymer interaction was investigated using Fourier Transformed Infrared Spectroscopy (FTIR).
Results. The results showed that the particle had good flow properties, encapsulation efficiency (56.11 ± 1.51–81.02 ± 2.14%) and cumulative drug release (64.14 ± 0.83–79.69 ± 2.45%) in a phosphate buffer (pH 6.8) after 10 h of the dissolution study. An increased particle size was observed with an increasing polymer concentration. It was observed that the Eudragit had a positive effect on the drug encapsulation and negative effect on drug release. Aggregation of drug-polymer droplets was observed at a lower level of magnesium stearate during microsphere preparation. The results of FTIR spectroscopy revealed the absence of any drug-polymer interactions. However, slight peak shifting and suppression in peak height was observed. This might be due to the minor ionic interactions. The microspheres were discrete, spherical and free-flowing. The spherical shape of the microspheres was confirmed from SEM photomicrographs. The developed microspheres showed a controlled drug release and were found to follow Higuchi’s model. The release mechanism of metronidazole from the microspheres was Fickian diffusion without swelling.
Conclusion. The results suggest that the developed microspheres could enhance drug entrapment, and inflect the drug release.

Key words

microspheres, inflammatory bowel diseases, colon targeting, emulsification-solvent evaporation

References (11)

  1. Vaidya A., Jain A., Khare P., Agrawal R.K., Jain S.K.: Metronidazole loaded pectin microspheres for colon targeting. J. Pharm. Sci. 2009, 98(11), 4229–4236.
  2. Philip A.K., Philip B.: Colon targeted drug delivery systems: A review on primary and novel approaches. Oman Med. J. 2010, 20(02), 70–78.
  3. Nicholas M.E., Panaganti S., Prabakaran L., Jayveera K.N.: Novel colon specific drug delivery system: A review. Int. J. Pharm. Sci. Res. 2011, 02(10), 2545–2561.
  4. Rutgeerts P., Hiele M., Geboes K., Peeters M., Penninckx F., Aerts R., Kerremans R.: A placebo controlled trial of metronidazole for recurrence prevention of Crohn’s disease after resection of the terminal ileum. Gastroenterology 1995, 108, 1617–1621.
  5. Rutgeerts P., Van Assche G., Vermeire S., D’Haens G., Baert F., Noman M., Aerden I., de Hertogh G., Geboes K., Hiele M., D’Hoore A., Penninckx F.: Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005, 128, 856–861.
  6. Sahoo S.K., Mallick A.A., Barik, B.B., Senapati P.C.: Formulation and in vitro evaluation of Eudragit microspheres of stavudine. Trop. J. Pharma Res. 2005, 04, 369–375.
  7. Wells J.I., Aultom M.E.: Pharmaceutical preformulation. In: Pharmaceutics: the design and manufacture of medicines. Ed.: Aulton M.E., Elsevier, Churchill Livingstone, London 2007, 3rd ed., 336–360.
  8. Awasthi R., Kulkarni G.T.: Development and characterization of amoxicillin loaded floating microballoons for the treatment of Helicobacter pylori induced gastric ulcer. Asian J. Pharm. Sci. 2013, 8, 174–180.
  9. Vandana D., Garg G., Dhameja K., Awasthi R.: Preparation, characterization and evaluation of ranitidine hydrochloride loaded mucoadhesive microspheres for controlled drug delivery. Polim. Med. 2014, 44(2), 75–81.
  10. Awasthi R., Kulkarni G.T., Pawar V.K., Garg G.: Optimization studies on gastroretentive floating system using response surface methodology. AAPS PharmSciTech 2012, 13, 85–93.
  11. Costa P., Lobo J.M.S.: Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13, 123–133.